Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,446,947
+$410,806 QoQ
Shares Held
9,724
+3.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#1,806
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Sep 30, 2024CallValue
$592,440
CallShares
3,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Focused Wealth Management, Inc holds $11,871,008 across 7 Drug Manufacturers - General names. ABBV ranks #3 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
119,833 | $2,885,578 | |
| 2 | LLY |
ELI LILLY & Co
|
2,178 | $2,612,358 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
9,724 | $2,446,947 | |
| 4 | JNJ |
Johnson & Johnson
|
8,891 | $2,258,047 | |
| 5 | MRK |
Merck & Co., Inc.
|
7,826 | $1,005,641 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,585 | $437,047 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,784 | $225,390 |
All Filings in ABBV
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,446,947 | 9,724 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,036,141 | 9,362 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,957,930 | 8,569 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,951,187 | 8,427 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $1,471,224 | 7,926 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,604,085 | 7,656 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $1,021,952 | 5,751 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $592,440 | 3,000 | Call | Sole | 2024-10-30 | |
| 2024-09-30 | $1,232,472 | 6,241 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $1,066,168 | 6,216 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,148,140 | 6,305 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $944,387 | 6,094 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $883,478 | 5,927 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $787,227 | 5,843 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $964,347 | 6,051 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $944,610 | 5,845 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $451,750 | 3,366 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $469,129 | 3,063 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $526,857 | 3,250 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $437,748 | 3,233 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $346,478 | 3,212 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $338,032 | 3,001 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $322,820 | 2,983 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $296,269 | 2,765 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $246,741 | 2,817 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $400,181 | 4,076 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $121,065 | 1,589 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||